Keywords
epidemiological profile
associated factors
complications
How to Cite
Abstract
Introduction
The Mpox outbreak in non-endemic regions has recently attracted global attention. The Isangi Territory has experienced Mpox epidemic outbreaks in recent years, during which several deaths were reported.
Purpose
This study aimed to describe the epidemiological profile of Mpox and to identify the factors associated with the occurrence of complications.
Methods
An analytical cross-sectional study was conducted in three health zones of the Isangi Territory, covering the period from January 2023 to January 2024. It included 230 patients with PCR-confirmed Mpox infection. Factors associated with the occurrence of complications were analysed using Odds Ratios (OR) and 95% Confidence Intervals (CI).
Results
The annual incidence of Mpox was 0.043%, with a case fatality rate of 4.7%. The median age of patients was 20 years (IQR: 5–25), and females were slightly more affected (54.8%). Most cases (99%) had no history of smallpox vaccination. Significant risk factors for complications included: age under 17 years (OR = 61.7, 95% CI: 24.8–160.1, p < 0.001), history of malnutrition and/or measles (OR = 34.9, 95% CI: 11.7–134.5, p < 0.001), seeking initial care from prayer sites or traditional healers (OR = 34.4, 95% CI: 15.0–82.7, p < 0.001), low socioeconomic status (OR = 4.7, 95% CI: 1.3–25.8, p = 0.009), and a higher education level was found to be a protective factor (OR = 0.4, 95% CI: 0.2–0.7, p = 0.001).
Conclusion
Complications related to Mpox infection are associated with sociodemographic, economic, and healthcare-related factors. Targeted interventions are needed to address each of these risk elements.
References
Beer, E. M., & Rao, V. B. (2019). A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Neglected Tropical Diseases, 13(7), e0007791. https://doi.org/10.1371/journal.pntd.0007791
Billioux, B. J., Mbaya, O. T., Sejvar, J., & Nath, A. (2022). Potential complications of monkeypox. The Lancet Neurology, 21(9), 872. https://doi.org/10.1016/S1474-4422(22)00340-4
Division Provinciale de la Santé/Tshopo. (2023). Revue annuelle 2023 [Internal document]. Tshopo, Democratic Republic of the Congo
Durski, K. N., McCollum, A. M., Nakazawa, Y., Hughes, C. M., Kotek, A. M., & Morgan, D. (2018). Emergence of Monkeypox—West and Central Africa, 1970–2017. MMWR. Morbidity and Mortality Weekly Report, 67(10), 306–310. https://doi.org/10.15585/mmwr.mm6710a5
EDS-RDC II. (2014). Enquête Démographie et Santé RDC 2013-2014 [Internal document]. Kinshasa, Democratic Republic of the Congo
Hoff, N. A., Doshi, R. H., Colwell, B., Kebela-Illunga, B., Mukadi, P., Mossoko, M., ... & Muyembe, J. J. (2017). Evolution d'un système de surveillance des maladies: une augmentation de la notification de la maladie de la variole du singe humaine en République démocratique du Congo, 2001-2013. International Journal of Tropical Diseases & Health, 25(2). https://doi.org/10.9734/IJTDH/2017/35885
Huang, Y., Mu, L., & Wang, W. (2022). Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy, 7(1), Article 373. https://doi.org/10.1038/s41392-022-01215-4
Huhn, G. D., Bauer, A. M., Yorita, K., Graham, M. B., Sejvar, J., Likos, A., ... & Kuehnert, M. J. (2005). Clinical characteristics of human monkeypox and risk factors for severe disease. Clinical Infectious Diseases, 41(12), 1742–1751. https://doi.org/10.1086/498115
Li, H., Zhang, H., Ding, K., Wang, X. H., Sun, G. Y., Liu, Z. X., & Luo, Y. (2022). The evolving epidemiology of monkeypox virus. Cytokine & Growth Factor Reviews, 68, 1–12. https://doi.org/10.1016/j.cytogfr.2022.10.002
Majie, A., Saha, R., & Sarkar, B. (2023). The outbreak of the monkeypox virus in the shadow of the pandemic. Environmental Science and Pollution Research International, 30(17), 48686–48702. https://doi.org/10.1007/s11356-023-26098-y
Mandja, B. M., Brembilla, A., Handschumacher, P., Eholie, S. P., Lokombe, B. L., Kabamba, J., ... & Muyembe, J. J. (2019). Temporal and spatial dynamics of monkeypox in Democratic Republic of Congo, 2000-2015. EcoHealth, 16(4), 476–487. https://doi.org/10.1007/s10393-019-01445-6
Mbala, P. K., Huggins, J. W., Riu-Rovira, T., Ahuka, S. M., Mulembakani, P. M., Rimoin, A. W., Martin, J. W., & Muyembe, J. J. (2017). Maternal and Fetal Outcomes in Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo. The Journal of Infectious Diseases, 216(7), 824–828. https://doi.org/10.1093/infdis/jix260
Nguyen, P. Y., Ajisegiri, W. S., Costantino, V., Muyembe, J. J., & Rimoin, A. W. (2021). Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020. Emerging Infectious Diseases, 27(4). https://doi.org/10.3201/eid2704.203569
Ogoina, D., Iroezindu, M., James, H. I., Oladokun, R., Yinka-Ogunleye, A., Wakama, P., ... & Ihekweazu, C. (2020). Clinical Course and Outcome of Human Monkeypox in Nigeria. Clinical Infectious Diseases, 71(8), e210–e214. https://doi.org/10.1093/cid/ciaa143
Patel, V. M., & Patel, S. V. (2023). Epidemiological Review on Monkeypox. Cureus, 15(2), e34653. https://doi.org/10.7759/cureus.34653
Petersen, E., Abubakar, I., Ihekweazu, C., Zumla, A., & Heymann, D. L. (2019b). Monkeypox: enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. International Journal of Infectious Diseases, 78, 78–84. https://doi.org/10.1016/j.ijid.2018.11.008
Petersen, E., Kantele, A., Koopmans, M., Asogun, D., Ihekweazu, C., & Zumla, A. (2019a). Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infectious Disease Clinics of North America, 33(4), 1027–1043. https://doi.org/10.1016/j.idc.2019.03.001.
PNLM/FHV. (2022). Fiche d’investigation de cas de monkeypox du programme national de lutte contre le Monkeypox et fièvres hémorragiques virales [Document interne].
Rimoin, A. W., Mulembakani, P. M., Johnston, S. C., Lloyd, K., Kasongo, W., Formenty, P., ... & Muyembe, J. J. (2010). Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences, 107(37), 16262–16267. https://doi.org/10.1073/pnas.1005769107
Simpson, K., Heymann, D., Brown, C. S., Edmunds, W. J., & Burki, F. (2020). Human monkeypox: after 40 years, an unintended consequence of smallpox eradication. Vaccine, 38(50), 77-81. https://doi.org/10.1016/j.vaccine.2020.04.062
Sklenovská, N., & Van Ranst, M. (2018). Emergence of monkeypox as the most important orthopoxvirus infection in humans. Frontiers in Public Health, 6, 1 241. https://doi.org/10.3389/fpubh.2018.00241
UK Health Security Agency. (2022). Monkeypox Outbreak: Technical Briefings. Retrieved March 31, 2023, from https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings
WHO. (2022a). Multi-country Monkeypox Outbreak: Situation Update. Retrieved March 29, 2023, from https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392
WHO. (2022b). Prise en charge clinique, prévention et maîtrise de l’orthopoxvirose simienne (variole du singe) : orientations provisoires pour une intervention rapide. Retrieved April 20, 2023, from 22093_FR_Clinical Management and Infection Prevention Control for Monkeypox –Emergency Rapid Response Guidance_25-07-22
Yinka-Ogunleye, A., Aruna, O., Dalhat, M., Ogoina, D., McCollum, A., & Ihekweazu, C. (2019). Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. The Lancet Infectious Diseases, 19(8), 872–879. https://doi.org/10.1016/S1473-3099(19)30257-X
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.